Abstract:Introduction: Endothelial dysfunction is considered a key contributor to vascular pathologies. It is well-accepted that excessive reactive oxygen species and oxidative damage likely contribute to endothelial dysfunction. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is considered the master regulator of endogenous antioxidant responses. Therefore, Nrf2 may be a potential therapeutic target to protect against endothelial dysfunction. However, the roles of endothelial cell (EC)-specific Nrf2 on endothelial function are not known. The major objective of this study was to evaluate the impacts of EC Nrf2 deletion on endothelial-mediated vasodilation, which we hypothesized would be attenuated with EC Nrf2 deletion. Methods: Femoral-to-popliteal artery segments were harvested from 6-mo old C57BL/6 mice (WT, n = 6) and EC-specific Nrf2-knockout mice (Tie2-Cre-Nrf2 floxed-KO, n = 6) using both sexes (3 male and 3 female/group). Vasodilation was assessed in response to flow (30 uL·min -1 ), acetylcholine (ACh, 10 -7 -10 -3 M) with and without NΩ-Nitro-L-arginine methyl ester (L-NAME), and sodium nitroprusside (SNP, 10 -9 -10 -4 M) using videomicroscopy. Glutathione peroxidase 1 (GPX1) and catalase (CAT) skeletal muscle protein expression was assessed by immunoblotting and normalized to total protein. Results: Endothelium-dependent vasodilation was lower in Nrf2-KO compared to WT induced by flow (WT: 34.8 ± 2.9%, Nrf2-KO: 20.7 ± 3.7%, P < 0.01) and ACh (10 -3 M, WT: 68.3 ± 8.2%, Nrf2-KO: 44.5 ± 7.1%, P < 0.01). L-NAME incubation attenuated endothelium-dependent vasodilation in WT mice in response to flow (12.8 ± 4.5%, P < 0.01) and ACh (10 -3 M, 19.1 ± 4.4%, P < 0.01) but did not change in Nrf2-KO in response to flow (15.6 ± 6.8%, P = 0.28) or ACh (10 -3 M, 37.7 ± 7.0%, P = 0.16). Endothelium-independent vasodilation was not different (SNP 10 -4 M, WT: 92.7 ± 3.6%, Nrf2-KO: 81.9 ± 10.2%, P = 0.16). In addition, GPX1 was lower in Nrf2-KO mice (WT: 0.47 ± 0.06, Nrf2-KO: 0.001 ± 0.003, P < 0.01), but CAT was not different (WT: 0.16 ± 0.04, Nrf2-KO: 0.37 ± 0.21, P = 0.08). Conclusions: EC Nrf2 may play a key role in endothelial-mediated vasodilatory function. The nitric oxide synthase inhibitor L-NAME attenuated endothelial-mediated vasodilation in WT but not in EC Nrf2-KO. EC Nrf2 may play a role in skeletal muscle antioxidant homeostasis, which suggests potential systemic implications of EC Nrf2 deletion. These results suggest that the EC antioxidant defense system is linked to endothelial dysfunction and changes in the skeletal muscle redox environment, likely through nitric oxide- and oxidative stress-related mechanisms. NIH (R01 AG034995, R01 AG049868, P01HL62222) NIH National Institute of General Medical Sciences, which funds the Great Plains IDeA-CTR Network (U54GM115458) This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Effects of Nrf2 deficiency on mitochondrial oxidative stress in aged skeletal muscle

Nrf2 Deficiency Exacerbates Frailty and Sarcopenia by Impairing Skeletal Muscle Mitochondrial Biogenesis and Dynamics in an Age-Dependent Manner.

Nrf2 Contributes to the Benefits of Exercise Interventions on Age-Related Skeletal Muscle Disorder Via Regulating Drp1 Stability and Mitochondrial Fission.

Nrf2 deficiency promotes the increasing trend of autophagy during aging in skeletal muscle: a potential mechanism for the development of sarcopenia

Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice

Impaired Transcriptional Activity of Nrf2 in Age-Related Myocardial Oxidative Stress Is Reversible by Moderate Exercise Training

Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology

Transcription Factor Nrf2 and Mitochondria - Friends or Foes in the Regulation of Aging Rate

Overexpression of Skeletal Muscle Nrf2 Protects Against Aging -Associated Dysfunction in Skeletal Muscle and Heart

Functional, Proteomic and Bioinformatic Analyses of Nrf2- and Keap1- Null Skeletal Muscle.

Reduced NRF2 expression suppresses endothelial progenitor cell function and induces senescence during aging

Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress

Endothelial Nrf2-KO Attenuates Endothelial Function and Skeletal Muscle Antioxidant Capacity

Mitochondrial ALDH2 deficiency promotes fibrosis and reactive oxygen species formation in the myocardium of aged mice

Chronic Endurance Exercise Impairs Cardiac Structure and Function in Middle-Aged Mice with Impaired Nrf2 Signaling

Skeletal Muscle-Specific Keap1 Disruption Modulates Fatty Acid Utilization and Enhances Exercise Capacity in Female Mice

The Role of Skeletal Muscle Nrf2 on Cardiac Function in Mice

Deletion of Nrf1 exacerbates oxidative stress-induced cellular senescence by disrupting the cell homeostasis

Mitochondrial ALDH2 Deficiency Promotes Fibrosis and ROS Formation in the Myocardium of Aged Mice

Muscle-specific Keap1 deletion enhances force production but does not prevent inactivity-induced muscle atrophy in mice

Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress